miR-125a-5p inhibits colorectal cancer cell epithelial-mesenchymal transition, invasion and migration by targeting TAZ
- PMID: 31190857
- PMCID: PMC6511622
- DOI: 10.2147/OTT.S191247
miR-125a-5p inhibits colorectal cancer cell epithelial-mesenchymal transition, invasion and migration by targeting TAZ
Abstract
Background: miR-125a-5p regulated biological processes in various types of cancer, including colorectal cancer (CRC). TAZ, a vital transcriptional coactivators of the Hippo pathway, was found to be overexpressed in various cancers. Objectives: This study aims to study the effect of miR-125a-5p on the progression of CRC by regulating TAZ expression. Methods: In this study, miR-125a-5p and TAZ expression in CRC tissue and cell lines were detected by real-time polymerase chain reaction (RT-PCR). Luciferase reporter assay was applied to detect whether TAZ was a target of miR-125a-5p. Cell migration and invasion were detected in vitro by wound-healing assay and cell invasion assay. Western blot was used to detect the expression of epithelial-mesenchymal transition (EMT)-related proteins. Findings: The results revealed downregulation of miR-125a-5p, as well as upregulation of TAZ in CRC tissue and cell lines. TAZ was identified as a direct target of miR-125a-5p, and its expression was negatively regulated by miR-125a-5p in CRC cell lines. The functional studies revealed that overexpression of miR-125a-5p inhibited the migration, invasion and EMT of CRC cells, while upregulation of TAZ reversed the inhibitory effect caused by miR-125a-5p. Conclusion: Our data suggest that miR-125a-5p inhibits CRC cell migration, invasion and EMT by targeting TAZ. These results suggest that miR-125a-5p serves as a potential therapeutic biomarker for CRC patients.
Keywords: TAZ; colorectal cancer; epithelial–mesenchymal transition; invasion; miR-125a-5p; migration.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Figures




Similar articles
-
miR-125a-5p promotes gastric cancer growth and invasion by regulating the Hippo pathway.J Clin Lab Anal. 2021 Dec;35(12):e24078. doi: 10.1002/jcla.24078. Epub 2021 Oct 28. J Clin Lab Anal. 2021. PMID: 34708891 Free PMC article.
-
MiR-125a-5p inhibits EMT of ovarian cancer cells by regulating TAZ/EGFR signaling pathway.Eur Rev Med Pharmacol Sci. 2019 Oct;23(19):8249-8256. doi: 10.26355/eurrev_201910_19134. Eur Rev Med Pharmacol Sci. 2019. PMID: 31646555
-
MiR-34a-5p Inhibits Proliferation, Migration, Invasion and Epithelial-mesenchymal Transition in Esophageal Squamous Cell Carcinoma by Targeting LEF1 and Inactivation of the Hippo-YAP1/TAZ Signaling Pathway.J Cancer. 2020 Mar 4;11(10):3072-3081. doi: 10.7150/jca.39861. eCollection 2020. J Cancer. 2020. PMID: 32226522 Free PMC article.
-
The miRNA125a-5p and miRNA125b-1-5p cluster induces cell invasion by down-regulating DDB2-reduced epithelial-to-mesenchymal transition (EMT) in colorectal cancer.J Gastrointest Oncol. 2022 Dec;13(6):3112-3122. doi: 10.21037/jgo-22-1222. J Gastrointest Oncol. 2022. PMID: 36636074 Free PMC article.
-
miR-125a-5p suppresses colorectal cancer progression by targeting VEGFA.Cancer Manag Res. 2018 Nov 16;10:5839-5853. doi: 10.2147/CMAR.S161990. eCollection 2018. Cancer Manag Res. 2018. PMID: 30510452 Free PMC article.
Cited by
-
CircularRNA circPARP4 promotes glioblastoma progression through sponging miR-125a-5p and regulating FUT4.Am J Cancer Res. 2021 Jan 1;11(1):138-156. eCollection 2021. Am J Cancer Res. 2021. PMID: 33520365 Free PMC article.
-
Differentially Expressed microRNAs in Peritoneal Dialysis Effluent-Derived Exosomes from the Patients with Ultrafiltration Failure.Genet Res (Camb). 2022 Aug 31;2022:2276175. doi: 10.1155/2022/2276175. eCollection 2022. Genet Res (Camb). 2022. PMID: 36101746 Free PMC article.
-
miRNA Clusters with Down-Regulated Expression in Human Colorectal Cancer and Their Regulation.Int J Mol Sci. 2020 Jun 29;21(13):4633. doi: 10.3390/ijms21134633. Int J Mol Sci. 2020. PMID: 32610706 Free PMC article. Review.
-
Development of a cancer cells self‑activating and miR‑125a‑5p expressing poly‑pharmacological nanodrug for cancer treatment.Int J Mol Med. 2022 Aug;50(2):102. doi: 10.3892/ijmm.2022.5158. Epub 2022 Jun 15. Int J Mol Med. 2022. PMID: 35703361 Free PMC article.
-
miR-125a-5p post-transcriptionally suppresses GALNT7 to inhibit proliferation and invasion in cervical cancer cells via the EGFR/PI3K/AKT pathway.Cancer Cell Int. 2020 Apr 10;20:117. doi: 10.1186/s12935-020-01209-8. eCollection 2020. Cancer Cell Int. 2020. PMID: 32308562 Free PMC article.
References
LinkOut - more resources
Full Text Sources